AR-11BD2E-11-2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAR-11BD2E-11-2

Drug Alias Nameanti-MCSP antigen mAb (ARIUS)anti-melanoma-associated chrondroitin sulfate proteoglycan monoclonal antibody (ARIUS)AR-004 series (ARIUS)AR-11BD2E-11-2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionChondroitin sulfate proteoglycans modulators

TargetsChondroitin sulfate proteoglycans

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArius Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArius Research Inc

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A